Parkinsonism & Related Disorders

Papers
(The H4-Index of Parkinsonism & Related Disorders is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study109
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?74
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents64
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors62
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia60
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia57
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease56
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS54
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease52
White matter connectivity networks predict early dementia conversion in Parkinson’s disease52
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease49
Chorea-Acanthocytosis: A Case Report46
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.44
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment44
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention44
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease40
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease36
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder35
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome35
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit34
Perry disease in an Argentine family due to the DCTN1 p.G67D variant33
Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?33
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease32
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school31
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease31
Bilateral Hemimasticatory spasm in a patient with hypereosinophilic syndrome30
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex30
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation30
A useful cognitive motor dual task paradigm in prodromal and manifest Huntington’s disease29
0.24313712120056